Literature DB >> 17324139

Identification of ligands binding specifically to inflammatory intestinal mucosa using phage display.

Tamaki Takagi1, Tomiyasu Arisawa, Kazumasa Yamamoto, Ichiro Hirata, Hiroshi Nakano, Makoto Sawada.   

Abstract

1. Even though current treatments for inflammatory bowel disease are effective, adverse reactions remain a problem. With the intention of developing a new drug delivery system, we attempted to identify molecules that are selectively adsorbed to inflamed bowel. 2. The PhD-C7C phage display peptide library was used for biopanning against mouse isolated bowel, either untreated (control) or with inflammation caused by ischaemia-reperfusion injury. One hundred clones were selected from among those obtained by two biopanning procedures and the amino acid sequences of these clones were identified by determination of the base sequences. 3. Then, 20 clones were selected by an alignment process, after which the three clones with the highest affinity for inflammatory bowel were identified. One of these three clones had significantly higher affinity for inflammatory bowel than for normal bowel. 4. In conclusion, biopanning against isolated bowel samples identified an amino acid sequence (SQSHPRH) with a specific high affinity for inflammatory bowel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324139     DOI: 10.1111/j.1440-1681.2007.04563.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell.

Authors:  Todd W Costantini; James G Putnam; Ritsuko Sawada; Andrew Baird; William H Loomis; Brian P Eliceiri; Vishal Bansal; Raul Coimbra
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 2.  The Screening of Therapeutic Peptides for Anti-Inflammation through Phage Display Technology.

Authors:  Kangran Zhang; Yezhong Tang; Qin Chen; Yang Liu
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.